Schrodinger, INC Form 4 insider transactions

NASDAQ
Yvonne Tran, EVP, CLO & CPO of Schrodinger, Inc., reports the acquisition of 60,000 stock options on March 4, 2024.
NASDAQ
Margaret Dugan, Chief Medical Officer of Schrodinger, Inc., was granted 60,000 stock options on March 4, 2024, according to a Form 4 filing with the SEC.
NASDAQ
Robert Lorne Abel, EVP and Chief Scientific Officer at Schrodinger, Inc., reported the grant of stock options on March 4, 2024.